1. Home
  2. PCVX vs DSGX Comparison

PCVX vs DSGX Comparison

Compare PCVX & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • DSGX
  • Stock Information
  • Founded
  • PCVX 2013
  • DSGX 1981
  • Country
  • PCVX United States
  • DSGX Canada
  • Employees
  • PCVX N/A
  • DSGX N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • PCVX Health Care
  • DSGX Technology
  • Exchange
  • PCVX Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • PCVX 9.6B
  • DSGX 8.4B
  • IPO Year
  • PCVX 2020
  • DSGX 1999
  • Fundamental
  • Price
  • PCVX $37.76
  • DSGX $100.83
  • Analyst Decision
  • PCVX Strong Buy
  • DSGX Buy
  • Analyst Count
  • PCVX 9
  • DSGX 12
  • Target Price
  • PCVX $147.50
  • DSGX $117.42
  • AVG Volume (30 Days)
  • PCVX 1.6M
  • DSGX 397.9K
  • Earning Date
  • PCVX 05-07-2025
  • DSGX 03-05-2025
  • Dividend Yield
  • PCVX N/A
  • DSGX N/A
  • EPS Growth
  • PCVX N/A
  • DSGX 22.39
  • EPS
  • PCVX N/A
  • DSGX 1.64
  • Revenue
  • PCVX N/A
  • DSGX $651,000,000.00
  • Revenue This Year
  • PCVX N/A
  • DSGX $13.20
  • Revenue Next Year
  • PCVX N/A
  • DSGX $12.03
  • P/E Ratio
  • PCVX N/A
  • DSGX $60.35
  • Revenue Growth
  • PCVX N/A
  • DSGX 13.63
  • 52 Week Low
  • PCVX $30.12
  • DSGX $87.20
  • 52 Week High
  • PCVX $121.06
  • DSGX $124.31
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 15.46
  • DSGX 42.14
  • Support Level
  • PCVX $68.36
  • DSGX $98.72
  • Resistance Level
  • PCVX $76.61
  • DSGX $106.46
  • Average True Range (ATR)
  • PCVX 3.45
  • DSGX 2.09
  • MACD
  • PCVX -2.06
  • DSGX 0.59
  • Stochastic Oscillator
  • PCVX 16.43
  • DSGX 39.27

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: